Yenher Holdings Bhd

Yenher Holdings Bhd maintains a strong liquidity position with a current ratio of 4.29, indicating the company can easily cover its short-term liabilities with its short-term assets. The company's cash and equivalents amount to MYR 19.14 million, which is a significant portion of its total assets of MYR 308.03 million. The liquidity_fpt metric suggests the company is well-positioned to manage its short-term obligations without external financing. In terms of profitability, Yenher Holdings Bhd reported a net income of MYR 20.68 million on revenue of MYR 291.44 million, resulting in a return on equity (ROE) of 7.72% and a return on assets (ROA) of 6.71%. These figures are in line with the industry's preferred metrics, which emphasize ROE and ROA as key indicators of financial performance. The company's operating income of MYR 27.45 million and gross profit of MYR 54.04 million further support its profitability. The company operates as a single business segment, with no disclosed revenue concentration by geographic region or product line. However, its primary markets are Malaysia and several Southeast Asian and African countries. The lack of segmental or geographic breakdown suggests a relatively undiversified exposure, which could pose a risk if demand in any of these regions declines. Looking ahead, the company's growth trajectory is expected to remain stable. The outlook for the current fiscal year indicates a modest increase in revenue, supported by continued demand for animal health and nutrition products. The company's capital expenditure of MYR -36.70 million suggests a focus on maintaining rather than expanding its current operations. Analysts have provided a mean price target of MYR 1.20, with a strong-buy recommendation, indicating a generally positive outlook. The risk assessment for Yenher Holdings Bhd indicates low liquidity and dilution risks. The company has no immediate filing-based liquidity or dilution flags, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure. The absence of long-term debt and the presence of substantial cash reserves further support the company's financial stability. No dilution potential is identified in the basic shares outstanding, and no adjustments have been applied to the valuation metrics. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's financial statements and disclosures have not revealed any material risks or liabilities that would impact its operations in the near term. The company's continued focus on its core business of animal health and nutrition products, along with its strong liquidity position, supports its current financial stability.